Support Prostate Health at the Cellular Level
Most men don't think about prostate health until something forces them to. A change in sleep. Something that feels off. A quiet shift you can't quite name.
By the time you notice, changes at the cellular level in your prostate tissues have often been building for years.
That's the problem most supplements never address. They work from the outside in. They never focus on the source — the prostate cells themselves.
The difference with Libidon® A-16 is the mechanism.
✔ Supports healthy prostate cell function*
✔ Helps maintain normal urinary flow and bladder function*
✔ Supports libido, vitality and reproductive system health*
✔ Formulated with Khavinson peptide complex A-16
🧬 Why Prostate Function Changes With Age
As men age, there's an age-related decline in the concentration of regulatory peptides across your organs — including your prostate gland.
Your prostate cells rely on peptides as signaling molecules. These short-chain amino acid sequences regulate metabolism, protein synthesis, and cellular restoration. When peptide concentration decreases, prostate tissue function becomes less efficient.
This age-related cellular decline is what most supplements never address. Libidon A-16 goes to the source — the prostate cells themselves.
⚙️ How Libidon Works — The Cellular Advantage
Libidon® A-16 is a dietary supplement formulated with peptide complex A-16. It's derived from the prostate gland of young animals using patented filtration technology.
After absorption, the peptides are transported to prostate tissues via tissue-specific carrier mechanisms. Once there, they act as cellular-level signaling molecules — supporting:
• Healthy activity in prostate cells and prostate tissues*
• Normal prostate gland function and cellular metabolism*
• Normal protein synthesis within prostate tissue*
• Balanced cellular inflammatory response in the prostate*
• Normal function within the broader reproductive system*
Unlike generic supplements, this prostate gland peptide bioregulator is designed to work with your body's natural cellular processes — not around them.
Bryan's Note: I spent years researching peptide bioregulators across 94 countries. What sets Khavinson Peptides apart isn't marketing — it's the volume and consistency of the research. Over 800 peer-reviewed publications. Clinical studies confirmed across decades. The Saint Petersburg Institute built this science from the ground up. Libidon® A-16 is one of the most researched prostate peptide bioregulators available. That's not a claim. That's the record. — Bryan Rider, Founder, Rebel Peptides
🔬 The Research Behind Libidon A-16
Libidon® A-16 belongs to the Khavinson Peptides system — organ-specific peptide bioregulators developed at the Saint Petersburg Institute of Bioregulation and Gerontology. Dr. Vladimir Khavinson and his team have published over 800 peer-reviewed studies across more than 40 years of research.
The tissue-specific, selective effect of Libidon on prostate cells is grounded in published science.
Peptide Transport Mechanism — Khavinson et al., 2022
A review in the International Journal of Molecular Sciences explored how ultrashort peptides — the structural class that includes peptide complex A-16 — are transported into cells via tissue-specific carrier mechanisms. The authors concluded this mechanism likely underlies both the tissue specificity and geroprotective activity of these molecules.
Read on PubMed →
---
Prostatic Peptide Clinical Study — Tkachuk, Gorbachev and Khavinson, 1991
A clinical study in Urologiia i Nefrologiia investigated prostatic peptide complex activity in 307 men. The research team observed improvement across multiple measured parameters including urinary function, pain, sexual function, sleep, and general condition.
Read on PubMed →
Prostatic Peptide Clinical Study — Vozianov, Gorpinchenko and Khavinson, 1991
A separate clinical study investigated prostatic peptide complex in men with various prostate concerns. The researchers noted improvement in uroflowmetric index, copulative function, and spermatogenesis. The formulation was characterized as well-tolerated with no adverse reactions observed.
Read on PubMed →
Prostatic Peptides and Bladder Function — Barabanova, Gorbachev and Khavinson, 1993
Research in Fiziologicheskii Zhurnal examined the relationship between prostatic peptides and bladder smooth-muscle cell activity. The study found the peptide formulation enhanced functional activity of bladder smooth-muscle cells — confirming a connection between prostatic peptide activity and broader urinary tract function.
Read on PubMed →
---
This is peer-reviewed research. Published. Available on PubMed. The science behind taking Libidon A-16 is confirmed — not theoretical.
Read our full guide to Libidon A-16 and prostate peptide bioregulators →
LINK: https://www.rebelpeptides.com/blogs/news/peptides-for-prostate-health
📖 Research Context — For Educational Reference Only
The following describes the research context in which Khavinson prostatic peptides have been studied. It is provided for educational purposes only. Libidon® A-16 is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease.
Dr. Khavinson's research into prostate gland peptide bioregulators was conducted in the context of men's prostate issues of various genesis — including benign prostatic hyperplasia (BPH), prostate enlargement, prostate adenoma, chronic prostatitis, prostatitis, and inflammation. The clinical studies above involved men experiencing a range of age-related changes in prostate function, urination patterns, urinary flow, and bladder-related concerns.
The Khavinson research tradition also explored the relationship between prostatic peptides and the broader male reproductive system — including effects observed on libido, erection quality, ejaculate quality, and vitality.
None of this constitutes a basis for claiming that Libidon® A-16 treats, reduces, or prevents BPH, prostate cancer, chronic prostatitis, prostate adenoma, prostate enlargement, or any other disease or condition. Always consult your doctor before taking Libidon, especially if you have an existing prostate health concern.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
